View in EDS

A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancer.

Saved in:
Bibliographic Details
Title: A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancer.
Authors: Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA., Thomas A; Duke Cancer Institute, Duke University, Durham, North Carolina, USA., Althouse S; Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana, USA., Zang Y; Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana, USA., Conder E; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA., Burgos R; Van Andel Institute, Grand Rapids, Michigan, USA., Schneider BP; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA., Ballinger T; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA., Douglas E; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA., Ansley K; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA., Jang HJ; Van Andel Institute, Grand Rapids, Michigan, USA., Chung W; Coriell Institute for Medical Research, Camden, New Jersey, USA., Issa JP; Coriell Institute for Medical Research, Camden, New Jersey, USA., Nephew KP; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA., Rassool FV; University of Maryland School of Medicine, Baltimore, Maryland, USA.
Source: Cancer [Cancer] 2026 Apr 15; Vol. 132 (8), pp. e70407.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41980055
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Miller+KD%22">Miller KD</searchLink>; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+A%22">Thomas A</searchLink>; Duke Cancer Institute, Duke University, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Althouse+S%22">Althouse S</searchLink>; Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Zang+Y%22">Zang Y</searchLink>; Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Conder+E%22">Conder E</searchLink>; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Burgos+R%22">Burgos R</searchLink>; Van Andel Institute, Grand Rapids, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Schneider+BP%22">Schneider BP</searchLink>; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Ballinger+T%22">Ballinger T</searchLink>; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Douglas+E%22">Douglas E</searchLink>; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Ansley+K%22">Ansley K</searchLink>; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Jang+HJ%22">Jang HJ</searchLink>; Van Andel Institute, Grand Rapids, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Chung+W%22">Chung W</searchLink>; Coriell Institute for Medical Research, Camden, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Issa+JP%22">Issa JP</searchLink>; Coriell Institute for Medical Research, Camden, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Nephew+KP%22">Nephew KP</searchLink>; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Rassool+FV%22">Rassool FV</searchLink>; University of Maryland School of Medicine, Baltimore, Maryland, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2026 Apr 15; Vol. 132 (8), pp. e70407.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41980055
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cncr.70407
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70407
    Titles:
      – TitleFull: A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Miller KD
      – PersonEntity:
          Name:
            NameFull: Thomas A
      – PersonEntity:
          Name:
            NameFull: Althouse S
      – PersonEntity:
          Name:
            NameFull: Zang Y
      – PersonEntity:
          Name:
            NameFull: Conder E
      – PersonEntity:
          Name:
            NameFull: Burgos R
      – PersonEntity:
          Name:
            NameFull: Schneider BP
      – PersonEntity:
          Name:
            NameFull: Ballinger T
      – PersonEntity:
          Name:
            NameFull: Douglas E
      – PersonEntity:
          Name:
            NameFull: Ansley K
      – PersonEntity:
          Name:
            NameFull: Jang HJ
      – PersonEntity:
          Name:
            NameFull: Chung W
      – PersonEntity:
          Name:
            NameFull: Issa JP
      – PersonEntity:
          Name:
            NameFull: Nephew KP
      – PersonEntity:
          Name:
            NameFull: Rassool FV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 04
              Text: 2026 Apr 15
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0142
          Numbering:
            – Type: volume
              Value: 132
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Cancer
              Type: main
ResultId 1